Author profile
Editorial team for Peptide Therapy Guide.
From this author
Peptide Draw Calculator Peptide Draw Calculator In-Depth Analysis: Formulation Iteration Notes Peptide innovation exhibits clear interdisciplinary features, as material science, bioinformatics and bioprocess t…
Read guide →At least half a dozen biotechnology companies working on psychedelics saw their stocks rise following an executive order from the White House meant to encourage the development of these drugs for mental health…
Read guide →Dive Brief: Chiesi Group plans to buy KalVista Pharmaceuticals for $1.9 billion to acquire Ekterly, a newly launched pill for a rare swelling disorder called hereditary angioedema. KalVista won approval of the…
Read guide →Today, a brief rundown of news involving Amgen and Erasca, as well as updates from Rocket Pharma and Janux Therapeutics that you may have missed. The Food and Drug Administration has officially proposed that A…
Read guide →Dive Brief: Cytokinetics said Tuesday that its drug Myqorzo succeeded in a Phase 3 trial in people with a progressive heart condition, opening up a sizable market opportunity and separating the treatment from …
Read guide →Best Peptides To Get My Workflow Refinements for Quantitative Analysis of Best Peptides To Get Tailored side-chain modification can enhance peptide stability and improve retention within multi-component biolog…
Read guide →London drug developer Cytospire said Tuesday it raised £ 61 million, or $83 million, to finance its twist on a popular class of cancer drugs. Cytospire is making a new form of “T cell engagers,” a type of canc…
Read guide →Today, a brief rundown of news involving Inhibrx Biosciences and the Food and Drug Administration, as well as updates from Fractyl Health, Capricor Therapeutics and Argenx that you may have missed. Inhibrx Bio…
Read guide →Today, a brief rundown of news involving Assertio Holdings and Isomorphic Labs, as well as updates from Kyverna Therapeutics and AC Immune that you may have missed. Assertio Holdings has terminated a buyout de…
Read guide →Today, a brief rundown of news involving the Food and Drug Administration and Amgen, as well as updates from Vincentage Pharma and Parabilis Medicines that you may have missed. The Food and Drug Administration…
Read guide →La Digestion Des Peptides Acides Amines What's New with La Digestion Des Peptides Acides Amines: Updated Notes on Receptor Interaction Noticeable market momentum encourages more institutions to invest in pepti…
Read guide →Research Alliance III, a blank-check entity designed by investment firm RA Capital Management, has raised $75 million in an initial public offering for the purposes of merging into an existing biotechnology co…
Read guide →The fast rise of China’s biotechnology sector has put U.S. drugmakers and the investors who back them in a difficult position. A flexible regulatory environment and low development costs have propelled a trove…
Read guide →Today, a brief rundown of news involving Otsuka Pharmaceuticals and Pfizer, as well as updates from Takeda and Axsome Therapeutics and that you may have missed. A newly approved drug from Otsuka Pharmaceutical…
Read guide →An experimental drug from Revolution Medicines has proven broadly effective against an aggressive and tough-to-treat pancreatic tumor in a highly anticipated study result that could quickly change medical prac…
Read guide →Dive Brief: An RNA-based shot developed by GSK and Ionis Pharmaceuticals helped wipe out hepatitis B in about a fifth of the patients who received it in a pair of clinical trials, according to study results pu…
Read guide →A double-barreled cancer immunotherapy extended the lives of people with lung cancer in a closely watched trial that’s viewed as important for gauging the potential impact of the drug, known as ivonescimab, as…
Read guide →Fulcrum Therapeutics has begun a strategic review that may result in it getting sold, a move made after the company’s main medicine hit a possibly insurmountable obstacle. On Tuesday, Fulcrum disclosed that, l…
Read guide →For the estimated one in 100 people worldwide living with celiac disease, the burden of disease extends far beyond their plate. Living with celiac disease demands constant vigilance. Decades after celiac disea…
Read guide →Advisers to the Food and Drug Administration have thrown their support behind an experimental flu shot from Moderna, heightening the chance that the vaccine could soon complete a dramatic regulatory turnaround…
Read guide →